DeSci 2.0: How BIO Will Unleash a Biotech Revolution
- BIO is an autonomous, community-owned launchpad for scientific communities — what pump.fun or daos.fun is to memecoins, BIO will make the curation, formation and funding of scientific communities FUN, accessible and open.
- Recent upgrades to BIO Tokenomics (Bionomics) allocate 55%+ to the community to make true on our promise of being a community-owned launchpad. In year 1, BIO is 100% community-owned, all team and insiders vest over 6 years. Great science takes to come to fruition. Slowly, then all at once.
- The BIO Roadmap for the months ahead includes Mainnet launch and productizing the permissionless creation of AI-driven DeSci DAOs targeting cures for any disease, and the wildest scientific frontiers. We are here to accelerate all life forms.
DeSci is at a crossroads: new launchpad mechanisms, memecoins, and communities are spreading like wildfire — yet public infrastructure to launch, curate and accelerate DeSci DAOs is sorely lacking. DeSci needs liquidity, it needs standardized frameworks that create trust, and it needs robust crypto railways plugging scientists and patients into DeFi.
What if we could funnel memecoin liquidity into funding science? Crypto would be regarded in a completely different light by the public.
BIO’s mission is to become a permissionless launchpad and acceleration network that makes DeSci DAO creation as easy as spinning up a Subreddit. BioDAOs are Reddit communities with a bank account that can build real-world IP portfolios like pharma companies. A pump.fun or DAOS.FUN for onchain scientific communities, where patients, scientists and investors seed, scale and co-own new medicines and therapeutics outside the confines of traditional pharma. And commercialize them.
We’ve learned a great deal about bringing science onchain in recent years, having incubated over $70 million in value across the leading DeSci DAOs and funded tens of millions in research. From VitaDAO’s longevity projects VitaRNA and VitaFAST, to ValleyDAO’s HempKnit to HairDAO’s hair loss solutions.
Following the first wave of DeSci DAOs, we’ve begun incubating the next wave, inviting biotech builders and scientists to apply for acceleration and support from the BIO Protocol. The product of the protocol's labour is a network of BioDAOs, curated by BIO token holders who direct resources to the most promising onchain science into a leaderboard driven by tokenisation and bonding curve design mechanism. The best DAOs should quickly rise to the top and become fully autonomous.
In recent months, we’ve been inundated with incredible founder applicants. Early acceptances into Cohort 2 include:
- Long COVID Labs: Accelerating a cure for the 100M+ patients globally, and is led by ex-Stanford Neuroscientist Rohan Dixit, who self-treated his own Long COVID.
- Curetopia: Targeting the $1+ Trillion rare disease space, led by Ethan Perlstein, a Y-Combinator alumnus, Harvard PhD and rare disease entrepreneur, who brought a drug to Phase 3 clinical trial with just $5M (a fraction of the typical $100M+ costs).
- Quantum Biology DAO: Building quantum microscopes to observe quantum biological phenomena, led by MIT PhD Dr. Clarice Aiello, one of the world’s leading Quantum Biology scientists.
Upgrading Bionomics
As more funding, users and scientists enter the space, the vision and structure of the BIO Protocol is becoming clearer.Given the importance of an actively engaged community, we’ve proposed an upgrade to Bionomics that allocates a larger share of BIO tokens to the community and ecosystem participants. We've allocated over 13% of token supply back to the community. In year 1, almost 100% of tokens are owned by the community.
Notably, a significant portion of tokens allocated to the core team have been redirected to community control and a portion of @Molecule_dao allocation (amounting to 5% of the BIO supply) is being allocated to an Ecosystem Fund. One of the fund’s core mandates is to support the development of decentralized AI technologies that accelerate R&D in the network. We envision AI Research agents deeply integrated within and across BioDAOs, coordinating around-the-clock research efforts throughout the network.
Read more about the upgrades to Bionomics in BIOPSY-12 and in the BIO Docs.
BIO Roadmap
To achieve our goals of accelerating decentralized science, we’ve created a roadmap covering key milestones over the next 6 months. These milestones may change as the market evolves and community feedback shapes our trajectory, but these are our current north stars:
LF-accelerate
BIO's Genesis phase is completed, having raised over $35M for onchain science. These tokens make-up the BIO Treasury, a diverse bucket BioDAO assets and tokenized IP, which will accrue stakes in future BioDAOs as they're voted into the network.
It's time to accelerate biology!
